EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitHistorischer BeitragOpen Access

Clostridioides difficile infection: history, epidemiology, risk factors, prevention, clinical manifestations, treatment, and future options

Stefano Di Bella iD, Gianfranco Sanson, Jacopo Monticelli, Verena Zerbato, Luigi Principe, Mauro Giuffrè, Giuseppe Pipitone, Roberto Luzzati

Clinical Microbiology Reviews · 13.06.2024 · 37 (2)

DOI: 10.1128/cmr.00135-23 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical Microbiology Reviews, erschienen am 13.06.2024. Verfasst von Stefano Di Bella und 7 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Department of Medical, Surgical and Health Sciences, Trieste University, Trieste, Italy. Hauptthemen laut MEDLINE: Clostridium Infections, Clostridioides difficile. Die Arbeit wurde bisher 181-mal zitiert (Crossref) und nennt 780 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Clostridioides difficile infection (CDI) is one of the major issues in nosocomial infections. This bacterium is constantly evolving and poses complex challenges for clinicians, often encountered in real-life scenarios. In the face of CDI, we are increasingly equipped with new therapeutic strategies, such as monoclonal antibodies and live biotherapeutic products, which need to be thoroughly understood to fully harness their benefits. Moreover, interesting options are currently under study for the future, including bacteriophages, vaccines, and antibiotic inhibitors. Surveillance and prevention strategies continue to play a pivotal role in limiting the spread of the infection. In this review, we aim to provide the reader with a comprehensive overview of epidemiological aspects, predisposing factors, clinical manifestations, diagnostic tools, and current and future prophylactic and therapeutic options for C. difficile infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Clostridium InfectionsClostridioides difficileHumansRisk FactorsCross InfectionAnti-Bacterial AgentsHistory, 21st Century

Stichwörter der Autor:innen

Clostridioides difficileClostridium infectionsantibacterial agentsantibodies, monoclonalbacteriabacteriophagespreventionsurveillance

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Clinical Department of Medical, Surgical and Health Sciences, Trieste University, Trieste, Italy.
  • Infectious Diseases Unit, Trieste University Hospital (ASUGI), Trieste, Italy.
  • Microbiology and Virology Unit, Great Metropolitan Hospital "Bianchi-Melacrino-Morelli", Reggio Calabria, Italy.
  • Department of Internal Medicine (Digestive Diseases), Yale School of Medicine, Yale University, New Haven, Connecticut, USA.
  • Infectious Diseases Unit, ARNAS Civico-Di Cristina Hospital, Palermo, Italy.

ORCID-Profile: Stefano Di Bella

Zitieren

APA

Di Bella, S., Sanson, G., Monticelli, J., Zerbato, V., Principe, L., Giuffrè, M., Pipitone, G., & Luzzati, R. (2024). Clostridioides difficile infection: history, epidemiology, risk factors, prevention, clinical manifestations, treatment, and future options. Clinical Microbiology Reviews, 37(2). https://doi.org/10.1128/cmr.00135-23

Vancouver

Di Bella S, Sanson G, Monticelli J, Zerbato V, Principe L, Giuffrè M, et al. Clostridioides difficile infection: history, epidemiology, risk factors, prevention, clinical manifestations, treatment, and future options. Clinical Microbiology Reviews. 2024;37(2). doi:10.1128/cmr.00135-23

BibTeX
@article{DiBella2024,
  author = {Di Bella, Stefano and Sanson, Gianfranco and Monticelli, Jacopo and Zerbato, Verena and Principe, Luigi and Giuffrè, Mauro and Pipitone, Giuseppe and Luzzati, Roberto},
  title = {Clostridioides difficile infection: history, epidemiology, risk factors, prevention, clinical manifestations, treatment, and future options},
  journal = {Clinical Microbiology Reviews},
  year = {2024},
  volume = {37},
  number = {2},
  doi = {10.1128/cmr.00135-23}
}
Kostenlos starten →